Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties

In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?

(2020) Eleonora Truzzi et al.   Nanomaterials

Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages

(2019) Liang Pang et al.   PHARMACEUTICAL RESEARCH

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

(2019) Michael J A Reid et al.   LANCET

Mycobacterium tuberculosis infection of host cells in space and time

(2019) Claudio Bussi et al.   FEMS MICROBIOLOGY REVIEWS

Drug delivery of rifampicin by natural micelles based on inulin: Physicochemical properties, antibacterial activity and human macrophages uptake

(2019) Giuseppe Tripodo et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Role of liposomes size, surface charge and PEGylation on rheumatoid arthritis targeting therapy

(2019) Hongwei Ren et al.   ACS Applied Materials & Interfaces

Isoniazid and host immune system interactions: a proposal for a novel comprehensive mode of action

(2019) Saifur R. Khan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Challenges and controversies in childhood tuberculosis

(2019) Anja Reuter et al.   LANCET

PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib‐Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer

(2019) Yao Yang et al.   Advanced Healthcare Materials

Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

(2019) Patricia Marcianes et al.   AAPS PHARMSCITECH

Macrophage inflammatory and metabolic responses to graphene-based nanomaterials differing in size and functionalization

(2019) Mónica Cicuéndez et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination

(2018) Rong Yang et al.   ACS Nano

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis

(2018) Gibril J. Njie et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages

(2018) Ana Costa et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Delivery of NF-κB shRNA using carbamate-mannose modified PEI for eliminating cancer stem cells

(2018) Xiyu Ke et al.   Nanomedicine-Nanotechnology Biology and Medicine

Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections

(2018) Leon Chien-Wei Lin et al.   Advanced Healthcare Materials

Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages

(2018) Alexandre C. C. Vieira et al.   Artificial Cells Nanomedicine and Biotechnology

Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection

(2018) Gemma O'Connor et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA

(2017) Philip A LoBue et al.   LANCET INFECTIOUS DISEASES

Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles

(2016) Namrata Soni et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Broad-Spectrum Antimicrobial Star Polycarbonates Functionalized with Mannose for Targeting Bacteria Residing inside Immune Cells

(2016) Chuan Yang et al.   Advanced Healthcare Materials

Studies of Highly-Ordered Heterodiantennary Mannose/Glucose-Functionalized Polymers and Concanavalin A Protein Interactions Using Isothermal Titration Calorimetry

(2015) Ravi S. Loka et al.   BIOMACROMOLECULES

p-Aminophenyl-α-d-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain

(2015) Indu Singh et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Latent Mycobacterium tuberculosis Infection

(2015) Haileyesus Getahun et al.   NEW ENGLAND JOURNAL OF MEDICINE

Latent tuberculosis infection – Revisiting and revising concepts

(2015) Padmini Salgame et al.   TUBERCULOSIS

Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis

(2015) Kevin P. Fennelly et al.   Frontiers in Immunology

Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity

(2014) Ziyin Cui et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel

(2014) Piyush Kumar Sahu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Targeted nanoparticles with novel non-peptidic ligands for oral delivery

(2013) Anne des Rieux et al.   ADVANCED DRUG DELIVERY REVIEWS

Partial Biodistribution and Pharmacokinetics of Isoniazid and Rifabutin Following Pulmonary Delivery of Inhalable Microparticles to Rhesus Macaques

(2012) Rahul Kumar Verma et al.   MOLECULAR PHARMACEUTICS

The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species

(2011) Martin I. Voskuil et al.   Frontiers in Microbiology

Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages

(2010) Wangyang Yu et al.   PHARMACEUTICAL RESEARCH

Inhaled drug therapy for treatment of tuberculosis

(2010) Amit Misra et al.   TUBERCULOSIS

Latent TB Infection Treatment Acceptance and Completion in the United States and Canada

(2009) C. Robert Horsburgh et al.   CHEST

Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice

(2008) R. K. Verma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY